• Accueil >
  • Publications >
  • A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

10 juil. 2019Science Translational Medicine

DOI : 10.1126/scitranslmed.aav5467

Auteurs

Sabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, Alexandre Houy, Grace Jung, Thibaud Lefebvre, David Rombaut, Ismael Boussaid, Abderrahmane Bousta, François Guillonneau, Prunelle Perrier, Samar Alsafadi, Michel Wassef, Raphaël Margueron, Alice Rousseau, Nathalie Droin, Nicolas Cagnard, Sophie Kaltenbach, Susann Winter, Anne-Sophie Kubasch, Didier Bouscary, Valeria Santini, Andrea Toma, Mathilde Hunault, Aspasia Stamatoullas, Emmanuel Gyan, Thomas Cluzeau, Uwe Platzbecker, Lionel Adès, Hervé Puy, Marc-Henri Stern, Zoubida Karim, Patrick Mayeux, Elizabeta Nemeth, Sophie Park, Tomas Ganz, Léon Kautz, Olivier Kosmider, Michaëla Fontenay

Résumé

A variant erythroferrone contributes to hepcidin modulation and systemic iron accumulation in patients with SF3B1 -mutated myelodysplastic syndrome.

Membres

MARC-HENRI STERN

Directeur de recherche

MICHEL WASSEF

Chargé de recherche Inserm